US Stock MarketDetailed Quotes

IMRX Immuneering

Watchlist
  • 2.130
  • +0.080+3.90%
Close Nov 27 16:00 ET
  • 2.130
  • 0.0000.00%
Post 20:01 ET
66.14MMarket Cap-1081P/E (TTM)

Immuneering Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
-84.76%316.95K
-99.76%455
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
-84.76%316.95K
-99.76%455
Cost of revenue
0
-86.29%158.12K
0
Gross profit
0
-82.86%158.83K
102.74%455
Operating expense
9.68%15.27M
10.43%14.91M
4.98%15.33M
12.54%58.41M
105.13%28.69M
5.45%13.93M
15.50%13.51M
12.14%14.6M
49.09%51.9M
26.01%13.99M
Selling and administrative expenses
3.75%4.01M
5.17%4.25M
-6.05%4.12M
7.39%16.76M
308.38%16.77M
0.86%3.87M
9.21%4.05M
10.86%4.38M
88.67%15.61M
30.42%4.11M
-General and administrative expense
3.75%4.01M
5.17%4.25M
-6.05%4.12M
7.39%16.76M
308.38%16.77M
0.86%3.87M
9.21%4.05M
10.86%4.38M
88.67%15.61M
30.42%4.11M
Research and development costs
11.97%11.25M
12.69%10.65M
9.71%11.2M
14.77%41.62M
20.65%11.91M
7.33%10.05M
18.44%9.45M
12.72%10.21M
36.65%36.27M
24.17%9.87M
Depreciation amortization depletion
0.00%7.32K
0.00%7.32K
0.00%7.32K
-2.62%29.27K
0.01%7.32K
0.00%7.32K
0.00%7.32K
-9.70%7.32K
--30.05K
--7.32K
-Depreciation and amortization
0.00%7.32K
0.00%7.32K
0.00%7.32K
-2.62%29.27K
0.01%7.32K
0.00%7.32K
0.00%7.32K
-9.70%7.32K
--30.05K
--7.32K
Operating profit
-9.68%-15.27M
-10.43%-14.91M
-4.98%-15.33M
-12.89%-58.41M
-105.14%-28.69M
-5.60%-13.93M
-15.96%-13.51M
-12.95%-14.6M
-52.70%-51.75M
-25.81%-13.99M
Net non-operating interest income expense
-36.05%547.07K
-29.15%826.1K
-3.17%804.88K
255.56%3.61M
46.10%754.14K
283.67%855.53K
716.57%1.17M
527.35%831.27K
497.09%1.01M
261.25%516.17K
Non-operating interest income
-36.05%547.07K
-29.15%826.1K
-3.17%804.88K
255.56%3.61M
46.10%754.14K
283.67%855.53K
716.57%1.17M
527.35%831.27K
497.09%1.01M
261.25%516.17K
Other net income (expense)
-72.81%129.31K
-94.86%7.72K
-12.74%213.04K
515.31%1.33M
107.97%464.35K
293.59%475.6K
724.43%150.19K
336.52%244.13K
270.66%216.84K
287.67%223.28K
Other non- operating income (expenses)
-72.81%129.31K
-94.86%7.72K
-12.74%213.04K
515.31%1.33M
107.97%464.35K
293.59%475.6K
724.43%150.19K
336.52%244.13K
270.66%216.84K
287.67%223.28K
Income before tax
-15.90%-14.6M
-15.51%-14.08M
-5.80%-14.31M
-5.86%-53.47M
-107.39%-27.47M
1.94%-12.6M
-5.74%-12.19M
-4.86%-13.52M
-49.26%-50.51M
-19.42%-13.25M
Income tax
Net income
-15.90%-14.6M
-15.52%-14.08M
-5.17%-14.31M
-5.86%-53.47M
-13.88%-15.08M
1.94%-12.6M
-5.74%-12.19M
-5.49%-13.6M
-50.63%-50.51M
-22.82%-13.25M
Net income continuous Operations
-15.90%-14.6M
-15.51%-14.08M
-5.80%-14.31M
-5.86%-53.47M
-107.39%-27.47M
1.94%-12.6M
-5.74%-12.19M
-4.86%-13.52M
-50.63%-50.51M
-22.82%-13.25M
Minority interest income
Net income attributable to the parent company
-15.90%-14.6M
-15.52%-14.08M
-5.17%-14.31M
-5.86%-53.47M
-13.88%-15.08M
1.94%-12.6M
-5.74%-12.19M
-5.49%-13.6M
-50.63%-50.51M
-22.82%-13.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-15.90%-14.6M
-15.52%-14.08M
-5.17%-14.31M
-5.86%-53.47M
-13.88%-15.08M
1.94%-12.6M
-5.74%-12.19M
-5.49%-13.6M
-50.63%-50.51M
-22.82%-13.25M
Basic earnings per share
-13.95%-0.49
-9.30%-0.47
3.92%-0.49
1.57%-1.88
-4.00%-0.52
12.24%-0.43
2.27%-0.43
-4.08%-0.51
22.36%-1.91
-19.05%-0.5
Diluted earnings per share
-13.95%-0.49
-9.30%-0.47
3.92%-0.49
1.57%-1.88
-4.00%-0.52
12.24%-0.43
2.27%-0.43
-4.08%-0.51
22.36%-1.91
-19.05%-0.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 00000000-84.76%316.95K-99.76%455
Operating revenue --0--0--0--0--0--0--0--0-84.76%316.95K-99.76%455
Cost of revenue 0-86.29%158.12K0
Gross profit 0-82.86%158.83K102.74%455
Operating expense 9.68%15.27M10.43%14.91M4.98%15.33M12.54%58.41M105.13%28.69M5.45%13.93M15.50%13.51M12.14%14.6M49.09%51.9M26.01%13.99M
Selling and administrative expenses 3.75%4.01M5.17%4.25M-6.05%4.12M7.39%16.76M308.38%16.77M0.86%3.87M9.21%4.05M10.86%4.38M88.67%15.61M30.42%4.11M
-General and administrative expense 3.75%4.01M5.17%4.25M-6.05%4.12M7.39%16.76M308.38%16.77M0.86%3.87M9.21%4.05M10.86%4.38M88.67%15.61M30.42%4.11M
Research and development costs 11.97%11.25M12.69%10.65M9.71%11.2M14.77%41.62M20.65%11.91M7.33%10.05M18.44%9.45M12.72%10.21M36.65%36.27M24.17%9.87M
Depreciation amortization depletion 0.00%7.32K0.00%7.32K0.00%7.32K-2.62%29.27K0.01%7.32K0.00%7.32K0.00%7.32K-9.70%7.32K--30.05K--7.32K
-Depreciation and amortization 0.00%7.32K0.00%7.32K0.00%7.32K-2.62%29.27K0.01%7.32K0.00%7.32K0.00%7.32K-9.70%7.32K--30.05K--7.32K
Operating profit -9.68%-15.27M-10.43%-14.91M-4.98%-15.33M-12.89%-58.41M-105.14%-28.69M-5.60%-13.93M-15.96%-13.51M-12.95%-14.6M-52.70%-51.75M-25.81%-13.99M
Net non-operating interest income expense -36.05%547.07K-29.15%826.1K-3.17%804.88K255.56%3.61M46.10%754.14K283.67%855.53K716.57%1.17M527.35%831.27K497.09%1.01M261.25%516.17K
Non-operating interest income -36.05%547.07K-29.15%826.1K-3.17%804.88K255.56%3.61M46.10%754.14K283.67%855.53K716.57%1.17M527.35%831.27K497.09%1.01M261.25%516.17K
Other net income (expense) -72.81%129.31K-94.86%7.72K-12.74%213.04K515.31%1.33M107.97%464.35K293.59%475.6K724.43%150.19K336.52%244.13K270.66%216.84K287.67%223.28K
Other non- operating income (expenses) -72.81%129.31K-94.86%7.72K-12.74%213.04K515.31%1.33M107.97%464.35K293.59%475.6K724.43%150.19K336.52%244.13K270.66%216.84K287.67%223.28K
Income before tax -15.90%-14.6M-15.51%-14.08M-5.80%-14.31M-5.86%-53.47M-107.39%-27.47M1.94%-12.6M-5.74%-12.19M-4.86%-13.52M-49.26%-50.51M-19.42%-13.25M
Income tax
Net income -15.90%-14.6M-15.52%-14.08M-5.17%-14.31M-5.86%-53.47M-13.88%-15.08M1.94%-12.6M-5.74%-12.19M-5.49%-13.6M-50.63%-50.51M-22.82%-13.25M
Net income continuous Operations -15.90%-14.6M-15.51%-14.08M-5.80%-14.31M-5.86%-53.47M-107.39%-27.47M1.94%-12.6M-5.74%-12.19M-4.86%-13.52M-50.63%-50.51M-22.82%-13.25M
Minority interest income
Net income attributable to the parent company -15.90%-14.6M-15.52%-14.08M-5.17%-14.31M-5.86%-53.47M-13.88%-15.08M1.94%-12.6M-5.74%-12.19M-5.49%-13.6M-50.63%-50.51M-22.82%-13.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -15.90%-14.6M-15.52%-14.08M-5.17%-14.31M-5.86%-53.47M-13.88%-15.08M1.94%-12.6M-5.74%-12.19M-5.49%-13.6M-50.63%-50.51M-22.82%-13.25M
Basic earnings per share -13.95%-0.49-9.30%-0.473.92%-0.491.57%-1.88-4.00%-0.5212.24%-0.432.27%-0.43-4.08%-0.5122.36%-1.91-19.05%-0.5
Diluted earnings per share -13.95%-0.49-9.30%-0.473.92%-0.491.57%-1.88-4.00%-0.5212.24%-0.432.27%-0.43-4.08%-0.5122.36%-1.91-19.05%-0.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data